Log In

Dyadic International Inc. (DYAI)

VTT to Continue Validation of C1 Platform in Bioproduction

July 8, 2019
Report ID: 10980
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.
Get Report

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ā€˜Get Reportā€™ button to login and view the research report.

Not a Member? Click ā€˜Joinā€™ or ā€˜Get Reportā€™ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

ā€Œ
Dyadic International Inc.
Dyadic International Inc.
Healthcare
Biotechnology
Ticker
DYAI
Current Price
$1.9239 0.73%
Market Cap
$55.4M
Price Target
Refer to Report
Volume
78.9K
52wk Range
$1.12 - $2.4
Fundamental Analysis:
Log in to view
Rating: Log in to view
Advanced Market Data
Related Research Reports
2/8/2021
ā€Œ
Dropping Coverage
Dropping Coverage (DYAI)
0 min read
11/13/2020
ā€Œ
Q3 EPS: More to come over the next 12 months
Q3 EPS: More to come over the next 12 months (DYAI)
3 min read
8/14/2020
ā€Œ
Q2 EPS: Making Progress with C1 Technology
Q2 EPS: Making Progress with C1 Technology (DYAI)
3 min read
7/15/2020
ā€Œ
Another Pharmaceutical Partnership is Established
Another Pharmaceutical Partnership is Established (DYAI)
1 min read

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
Log In
Ā© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
Log In